Published in Am J Respir Crit Care Med on March 01, 1998
Both high level pressure support ventilation and controlled mechanical ventilation induce diaphragm dysfunction and atrophy. Crit Care Med (2012) 1.87
Chronic intrinsic transient tracheal occlusion elicits diaphragmatic muscle fiber remodeling in conscious rodents. PLoS One (2012) 0.82
Pulmonary adaptations to swim and inspiratory muscle training. Eur J Appl Physiol (2008) 0.79
Respiratory muscle plasticity. Compr Physiol (2012) 0.79
Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology. Heart Fail Rev (2016) 0.78
Partial Support Ventilation and Mitochondrial-Targeted Antioxidants Protect against Ventilator-Induced Decreases in Diaphragm Muscle Protein Synthesis. PLoS One (2015) 0.77
Intrinsic transient tracheal occlusion training and myogenic remodeling of rodent parasternal intercostal fibers. J Rehabil Res Dev (2014) 0.76
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J (1995) 7.03
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J (2002) 4.01
Six minute walking distance in healthy elderly subjects. Eur Respir J (1999) 3.56
Recommendations on the use of exercise testing in clinical practice. Eur Respir J (2007) 3.15
Bronchodilator responsiveness in patients with COPD. Eur Respir J (2008) 3.13
Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med (1996) 3.05
Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J (2006) 2.93
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax (2003) 2.68
New procedure for the isolation of membrane vesicles of Bacillus subtilis and an electron microscopy study of their ultrastructure. J Bacteriol (1973) 2.44
Regulation of mucociliary clearance in health and disease. Eur Respir J (1999) 2.43
Training with inspiratory pressure support in patients with severe COPD. Eur Respir J (2006) 2.18
Platypnea-orthodeoxia syndrome: a report of two cases. Acta Cardiol (1993) 2.17
Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J (2010) 2.01
Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med (2000) 1.89
Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J (2011) 1.80
Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J (2006) 1.77
Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax (2005) 1.71
Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J (1997) 1.63
Exercise training after lung transplantation improves participation in daily activity: a randomized controlled trial. Am J Transplant (2012) 1.62
Rehabilitation and acute exacerbations. Eur Respir J (2011) 1.53
Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Eur Respir J (2009) 1.52
Physiological basis of improvement after lung volume reduction surgery for severe emphysema: where are we? Eur Respir J (1999) 1.51
Reconstitution of reduced nicotinamide adenine dinucleotide oxidase activity with menadione in membrane vesicles from the menaquinone-deficient Bacillus subtilis aro D. Relation between electron transfer and active transport. Eur J Biochem (1976) 1.42
[Physiological effects of lung reduction surgery: the contribution of an animal model of emphysema]. Rev Mal Respir (2003) 1.39
Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.39
[COPD and bone metabolism: a clinical update]. Rev Mal Respir (2010) 1.37
Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. Eur Respir J (2002) 1.23
Cloning and nucleotide sequence of rat ornithine decarboxylase cDNA. Gene (1987) 1.21
Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur Respir J (2007) 1.19
Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J (2002) 1.19
Primary care spirometry. Eur Respir J (2008) 1.18
Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil (2000) 1.16
Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J (2002) 1.15
Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J (2008) 1.13
Rostrocaudal gradient of electrical activation in the parasternal intercostal muscles of the dog. J Physiol (1996) 1.13
Validation of two activity monitors in patients with COPD. Thorax (2009) 1.13
Authors' response to Walker et al. Thorax (2013) 1.09
The European Union conference on chronic respiratory disease: purpose and conclusions. Eur Respir J (2011) 1.08
2010: the year of the lung. Eur Respir J (2011) 1.07
Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma. Clin Pharmacol Ther (1997) 1.06
Corticosteroids decrease mRNA levels of SERCA pumps, whereas they increase sarcolipin mRNA in the rat diaphragm. J Physiol (2000) 1.06
Transport of L-glutamate and L-aspartate by membrane vesicles of Bacillus subtilis W 23. FEBS Lett (1972) 1.05
Exercise training in COPD: how to distinguish responders from nonresponders. J Cardiopulm Rehabil (2001) 1.05
A clinical practice guideline for physiotherapists treating patients with chronic obstructive pulmonary disease based on a systematic review of available evidence. Clin Rehabil (2009) 1.05
COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Respir Med (2010) 1.05
Effects of mechanical ventilation on diaphragm function and biology. Eur Respir J (2002) 1.04
Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest (2007) 1.04
High-frequency diaphragmatic flutter: symptoms and treatment by carbamazepine. Lancet (1992) 1.03
Contractile properties of intercostal muscles and their functional significance. J Appl Physiol (1985) (1985) 1.01
Maximal transrespiratory pressures in obstructive lung disease. Bull Eur Physiopathol Respir (1980) 1.01
Regional differences in abdominal pressure swings in dogs. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.00
Relation between reduced nicotinamide adenine dinucleotide oxidation and amino acid transport in membrane vesicles from Bacillus subtilis. J Bacteriol (1975) 1.00
Reversibility of paraneoplastic bilateral diaphragmatic paralysis after nephrectomy for renal cell carcinoma. Ann Oncol (2000) 1.00
Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered. Eur Respir J (1992) 0.99
Respiratory chain linked ferricy anide reduction drives active transport in membrane vesicles from Bacillus subtilis. FEBS Lett (1975) 0.99
Sinonasal pathology in nonallergic asthma and COPD: 'united airway disease' beyond the scope of allergy. Allergy (2007) 0.96
Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir Med (2013) 0.96
Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius. Am J Respir Crit Care Med (1999) 0.96
Model of elasticity of the human lung. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.96
Exercise training and pulmonary rehabilitation: new insights and remaining challenges. Eur Respir Rev (2010) 0.95
Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD. Eur Respir J (2007) 0.93
Effects of drugs on mucus clearance. Eur Respir J (1999) 0.92
Incentive spirometry does not enhance recovery after thoracic surgery. Crit Care Med (2000) 0.92
Pulmonary function and maximal transrespiratory pressures in ankylosing spondylitis. Ann Rheum Dis (1989) 0.92
Respiratory muscle weakness and respiratory muscle training in severely disabled multiple sclerosis patients. Arch Phys Med Rehabil (2000) 0.91
Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004. Thorax (2005) 0.91
Dicarboxylic acid transport in membrane vesicles from Bacillus subtilis. J Bacteriol (1975) 0.90
The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema. Eur Respir J (2011) 0.89
On the mechanism of the mediolateral gradient of parasternal activation. J Appl Physiol (1985) (1996) 0.89
Reliability of a commercially available threshold loading device in healthy subjects and in patients with chronic obstructive pulmonary disease. Thorax (1996) 0.89
Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Eur Respir J (2009) 0.89
Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study. Am J Transplant (2008) 0.88
Diagnostic value of transesophageal echocardiography in platypnea. J Am Soc Echocardiogr (1994) 0.88
Corticosteroid treatment and nutritional deprivation cause a different pattern of atrophy in rat diaphragm. J Appl Physiol (1985) (1995) 0.88